Pila Pharma AB (OSTO:PILA) Long-Term Debt : kr0.00 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Pila Pharma AB Long-Term Debt?

Pila Pharma AB's Long-Term Debt for the quarter that ended in Dec. 2024 was kr0.00 Mil.

Pila Pharma AB Long-Term Debt Historical Data

The historical data trend for Pila Pharma AB's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pila Pharma AB Long-Term Debt Chart

Pila Pharma AB Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Debt

Get a 7-Day Free Trial

Pila Pharma AB Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
Long-Term Debt	Get a 7-Day Free Trial													-	-	-	-	-

Pila Pharma AB (OSTO:PILA) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Pila Pharma AB Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Pila Pharma AB's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Pila Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pila Pharma AB (OSTO:PILA) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

5KC:Germany

Address

Norra Vallgatan 72, Malmo, SWE, 211 21

Website

https://www.pilapharma.com

Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.

Pila Pharma AB Headlines

No Headlines